Veterinary Medicines Information website

Nobilis Ma5 + Clone30, lyofilisaat en suspendeervloeistof voor oculonasale suspensie/gebruik in drinkwater voor kippen

Authorised
  • Infectious bronchitis virus, type Massachusetts, strain Ma5, Live
  • Newcastle disease virus, strain Clone 30, Live
Download as PDF

Product identification

Medicine name:
Nobilis Ma5 + Clone30, lyofilisaat en suspendeervloeistof voor oculonasale suspensie/gebruik in drinkwater voor kippen
Active substance:
  • Infectious bronchitis virus, type Massachusetts, strain Ma5, Live
  • Newcastle disease virus, strain Clone 30, Live
Target species:
  • Chicken
Route of administration:
  • In drinking water use
  • Oculonasal use
  • Nebulisation use

Product details

Active substance and strength:
  • Infectious bronchitis virus, type Massachusetts, strain Ma5, Live
    3.00
    log 10 50% embryo infective dose
    /
    1.00
    Dose
  • Newcastle disease virus, strain Clone 30, Live
    6.00
    log 10 50% embryo infective dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken
      • Meat and offal
        7
        day
      • Egg
        no withdrawal period
  • Oculonasal use
    • Chicken
      • Meat and offal
        7
        day
      • Egg
        no withdrawal period
  • Nebulisation use
    • Chicken
      • Meat and offal
        7
        day
      • Egg
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD11
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Intervet Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 8104
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 24/02/2022
Download